Ganglioglioma

Oncology·MeSH: Ganglioglioma

Prevalence

0.1 / 100K

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Ganglioglioma?

There are 2 clinical trials targeting Ganglioglioma tracked by BioSniper.

What is the prevalence of Ganglioglioma?

The estimated prevalence of Ganglioglioma is approximately 0.1 per 100,000 population.

Deep-dive into Ganglioglioma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Ganglioglioma — Drugs in Development & Clinical Trials | BioSniper